Literature DB >> 11246269

Alcohol and atherosclerosis.

P L daLuz1, S R Coimbra.   

Abstract

Atherosclerosis is manifested as coronary artery disease (CAD), ischemic stroke and peripheral vascular disease. Moderate alcohol consumption has been associated with reduction of CAD complications. Apparently, red wine offers more benefits than any other kind of drinks, probably due to flavonoids. Alcohol alters lipoproteins and the coagulation system. The flavonoids induce vascular relaxation by mechanisms that are both dependent and independent of nitric oxide, inhibits many of the cellular reactions associated with atherosclerosis and inflammation, such as endothelial expression of vascular adhesion molecules and release of cytokines from polymorphonuclear leukocytes. Hypertension is also influenced by the alcohol intake. Thus, heavy alcohol intake is almost always associated with systemic hypertension, and hence shall be avoided. In individuals that ingest excess alcohol, there is higher risk of coronary occlusion, arrhythmias, hepatic cirrhosis, upper gastrointestinal cancers, fetal alcohol syndrome, murders, sex crimes, traffic and industrial accidents, robberies, and psychosis. Alcohol is no treatment for atherosclerosis; but it doesn't need to be prohibited for everyone. Thus moderate amounts of alcohol (1-2 drinks/day), especially red wine, may be allowed for those at risk for atherosclerosis complications.

Entities:  

Mesh:

Year:  2001        PMID: 11246269     DOI: 10.1590/s0001-37652001000100006

Source DB:  PubMed          Journal:  An Acad Bras Cienc        ISSN: 0001-3765            Impact factor:   1.753


  3 in total

1.  Body mass index is associated with brain metabolite levels in alcohol dependence--a multimodal magnetic resonance study.

Authors:  Stefan Gazdzinski; Timothy C Durazzo; Anderson Mon; Dieter J Meyerhoff
Journal:  Alcohol Clin Exp Res       Date:  2010-09-07       Impact factor: 3.455

2.  The relationships of sociodemographic factors, medical, psychiatric, and substance-misuse co-morbidities to neurocognition in short-term abstinent alcohol-dependent individuals.

Authors:  Timothy C Durazzo; Johannes C Rothlind; Stefan Gazdzinski; Dieter J Meyerhoff
Journal:  Alcohol       Date:  2008-09       Impact factor: 2.405

3.  The atherogenic and metabolic impact of non-HDL cholesterol versus other lipid sub-components among non-diabetic and diabetic Saudis.

Authors:  Nasser M Al-Daghri; Omar S Al-Attas; Khalid Al-Rubeaan
Journal:  Lipids Health Dis       Date:  2007-04-04       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.